# Hemab Therapeutics Holdings, Inc. (COAG) insider trading

> In the 12 months to Nov 19, 2026, 2 COAG insiders reported open-market purchases of $55.5M across 8 filings; no open-market sales were filed.

Canonical: https://massive.com/quote/coag/insider-trading
Latest filing: 2026-09-25 (last 12 months; source: SEC EDGAR)
Source: Massive (https://massive.com/docs/llms.txt)

## Summary

| Measure | Value | Detail |
| --- | --- | --- |
| Open-market sales | $0 | 0 filings · 0 insiders |
| Open-market purchases | $55.5M | 8 filings |

## Open-market trades by insider

| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
| --- | --- | --- | --- | --- | --- | --- |
| Rajeev M. Shah | Director → 10% owner | — | $53.1M | 5 | — | 2026-06-17 |
| Peter Kolchinsky | Director → 10% owner | — | $2.3M | 3 | — | 2026-06-17 |

## Open-market trades by filing

8 filings in the last 12 months, newest first.

| Filed | Traded | Insider | Role | Type | Shares | Avg price | Value | Held after | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 2026-06-17 | 2026-06-15 | Peter Kolchinsky | 10% owner | Purchase | 6,146 | $24.89 | $153.0K | 6,383,114 | — |
| 2026-06-17 | 2026-06-16 | Rajeev M. Shah | 10% owner | Purchase | 61,523 | $24.98 | $1.5M | 6,444,637 | — |
| 2026-05-21 | 2026-05-19 | Rajeev M. Shah | 10% owner | Purchase | 4,798 | $24.96 | $119.8K | 6,376,968 | — |
| 2026-05-14 | 2026-05-12 | Rajeev M. Shah | 10% owner | Purchase | 6,387 | $24.90 | $159.0K | 6,372,170 | — |
| 2026-05-11 | 2026-05-07 | Peter Kolchinsky | 10% owner | Purchase | 24,055 | $24.47 | $588.5K | 6,340,063 | — |
| 2026-05-11 | 2026-05-08 | Rajeev M. Shah | 10% owner | Purchase | 27,203 | $25.00 | $680.0K | 6,365,783 | — |
| 2026-05-06 | 2026-05-05 | Peter Kolchinsky | Director | Purchase | 63,675 | $24.86 | $1.6M | 6,314,525 | — |
| 2026-05-06 | 2026-05-04 | Rajeev M. Shah | Director | Purchase | 2,776,754 | $18.24 | $50.6M | 6,261,118 | — |

## Other insider activity (not market trades)

- Other: 6 records

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

## How to read this page

- **Open-market purchase or sale**: A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- **Role**: The title on each filing. Someone whose title changed shows more than one.
- **Filing date**: Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
- **Counted once**: When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.

## FAQ

### How current is COAG’s insider data?

These are COAG Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.

### What counts as an open-market buy or sell?

Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.

## Live data

This page joins two Massive endpoints: Form 4 filings and daily prices. The COAG Form 4 request:

- `GET https://api.massive.com/stocks/filings/vX/form-4?tickers=COAG&filing_date.gte=2025-11-19&sort=filing_date.desc&limit=500`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Hemab Therapeutics Holdings, Inc. (COAG) stock price](https://massive.com/quote/coag.md)
- [Recent insider trading](https://massive.com/quote/insider-trading.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
